Back to top
more

Tandem Diabetes Care, Inc. (TNDM)

(Real Time Quote from BATS)

$29.92 USD

29.92
1,068,639

-3.57 (-10.66%)

Updated Nov 19, 2018 12:58 PM ET

Add to portfolio

3-Hold     3    

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1
2
3
4
5
S&P
Strong Buy
Buy
Hold
Sell
Strong Sell
500
25.32%
18.25%
9.79%
5.22%
2.14%
10.57%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

F Value | A Growth | A Momentum | B VGM

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

View All Zacks #1 Ranked Stocks

Trades from $1

The Zacks Equity Research reports, or ZER for short, are our in-house, independently produced research reports.

The ever popular one-page Snapshot reports are generated for virtually every single Zacks Ranked stock. It's packed with all of the company's key stats and salient decision making information. Including the Zacks Rank, Zacks Industry Rank, Style Scores, the Price, Consensus & Surprise chart, graphical estimate analysis and how a stocks stacks up to its peers.

The detailed multi-page Analyst report does an even deeper dive on the company's vital statistics. In addition to all of the proprietary analysis in the Snapshot, the report also visually displays the four components of the Zacks Rank (Agreement, Magnitude, Upside and Surprise); provides a comprehensive overview of the company business drivers, complete with earnings and sales charts; a recap of their last earnings report; and a bulleted list of reasons to buy or sell the stock. It also includes an industry comparison table to see how your stock compares to its expanded industry, and the S&P 500.

Researching stocks has never been so easy or insightful as with the ZER Analyst and Snapshot reports.

Learn more about Zacks Equity Research reports

See more Zacks Equity Research reports

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Brokerage Reports

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

Research for TNDM

   

The Zacks Equity Research reports, or ZER for short, are our in-house, independently produced research reports.

The ever popular one-page Snapshot reports are generated for virtually every single Zacks Ranked stock. It's packed with all of the company's key stats and salient decision making information. Including the Zacks Rank, Zacks Industry Rank, Style Scores, the Price, Consensus & Surprise chart, graphical estimate analysis and how a stocks stacks up to its peers.

The detailed multi-page Analyst report does an even deeper dive on the company's vital statistics. In addition to all of the proprietary analysis in the Snapshot, the report also visually displays the four components of the Zacks Rank (Agreement, Magnitude, Upside and Surprise); provides a comprehensive overview of the company business drivers, complete with earnings and sales charts; a recap of their last earnings report; and a bulleted list of reasons to buy or sell the stock. It also includes an industry comparison table to see how your stock compares to its expanded industry, and the S&P 500.

Researching stocks has never been so easy or insightful as with the ZER Analyst and Snapshot reports.

Learn more about Zacks Equity Research reports

See more Zacks Equity Research reports

0 items in cart

Tandem Diabetes Care, Inc. [TNDM]

Reports for Purchase

Showing records 1 - 20 ( 101 total )

Company: Tandem Diabetes Care, Inc.

Industry: Medical - Instruments

Record: 1

11/13/2018

Company Report

Pages: 7

Price: 24.95

Company: Tandem Diabetes Care, Inc.

Industry: Medical - Instruments

Record: 2

10/23/2018

Company Report

Pages: 10

ValuEngine Detailed Valuation Report for TNDM

Provider: ValuEngine, Inc

Price: 25.00

Research Provided by a Third Party

Company: Tandem Diabetes Care, Inc.

Industry: Medical - Instruments

Record: 3

10/09/2018

Company Report

Pages: 7

Price: 24.95

Company: Tandem Diabetes Care, Inc.

Industry: Medical - Instruments

Record: 4

10/08/2018

Company Report

Pages: 7

Price: 24.95

Company: Tandem Diabetes Care, Inc.

Industry: Medical - Instruments

Record: 5

10/05/2018

Company Report

Pages: 7

Price: 24.95

Company: Tandem Diabetes Care, Inc.

Industry: Medical - Instruments

Record: 6

05/04/2018

Daily Note

Pages: 4

Medical Devices -Dropping Coverage Due to Analyst Departure

Provider: Wedbush Securities Inc.

Price: 10.00

Research Provided by a Third Party

Company: Tandem Diabetes Care, Inc.

Industry: Medical - Instruments

Record: 7

10/27/2017

Daily Note

Pages: 10

MORNING CALL

Provider: Wedbush Securities Inc.

Price: 25.00

Research Provided by a Third Party

Company: Tandem Diabetes Care, Inc.

Industry: Medical - Instruments

Record: 8

10/27/2017

Company Report

Pages: 6

Qtr In Line with Pre-Announce; Momentum Positive Heading into 4Q

Provider: Wedbush Securities Inc.

Price: 25.00

Research Provided by a Third Party

Company: Tandem Diabetes Care, Inc.

Industry: Medical - Instruments

Record: 9

10/13/2017

Company Report

Pages: 7

Preannounces 3Q17 Results; Trends Improving in 4Q

Provider: Wedbush Securities Inc.

Price: 25.00

Research Provided by a Third Party

Company: Tandem Diabetes Care, Inc.

Industry: Medical - Instruments

Record: 10

10/10/2017

Daily Note

Pages: 47

Medical Devices - 3Q17 Earnings Preview: Anti-climatic due to Seasonally Soft Qtr and Hurricanes

Provider: Wedbush Securities Inc.

Price: 100.00

Research Provided by a Third Party

Company: Tandem Diabetes Care, Inc.

Industry: Medical - Instruments

Record: 11

08/16/2017

Daily Note

Pages: 8

MORNING CALL

Provider: Wedbush Securities Inc.

Price: 25.00

Research Provided by a Third Party

Company: Tandem Diabetes Care, Inc.

Industry: Medical - Instruments

Record: 12

08/16/2017

Industry Report

Pages: 9

Medical Devices - Healthcare Conference

Provider: Wedbush Securities Inc.

Price: 25.00

Research Provided by a Third Party

Company: Tandem Diabetes Care, Inc.

Industry: Medical - Instruments

Record: 13

07/28/2017

Daily Note

Pages: 15

MORNING CALL

Provider: Wedbush Securities Inc.

Price: 50.00

Research Provided by a Third Party

Company: Tandem Diabetes Care, Inc.

Industry: Medical - Instruments

Record: 14

07/28/2017

Company Report

Pages: 11

Results In line With Expectations; TNDM Continues to Gain Insulin Pump Share

Provider: Wedbush Securities Inc.

Price: 25.00

Research Provided by a Third Party

Company: Tandem Diabetes Care, Inc.

Industry: Medical - Instruments

Record: 15

07/18/2017

Daily Note

Pages: 42

2Q17 Earnings Preview: Positive Underlying Dynamics

Provider: Wedbush Securities Inc.

Price: 100.00

Research Provided by a Third Party

Company: Tandem Diabetes Care, Inc.

Industry: Medical - Instruments

Record: 16

06/12/2017

Industry Report

Pages: 6

Diabetes Technology Insights from the ADA

Provider: Wedbush Securities Inc.

Price: 25.00

Research Provided by a Third Party

Company: Tandem Diabetes Care, Inc.

Industry: Medical - Instruments

Record: 17

04/28/2017

Company Report

Pages: 8

Tandem 1Q17 Stands up to the Challenge; Reiterate OUTPERFORM

Provider: Wedbush Securities Inc.

Price: 25.00

Research Provided by a Third Party

Company: Tandem Diabetes Care, Inc.

Industry: Medical - Instruments

Record: 18

04/17/2017

Daily Note

Pages: 41

1Q17 Preview: Outperforming in MedTech Year-to-Date Reflects Stable Fundamentals That Should Continue Throughout 2017

Provider: Wedbush Securities Inc.

Price: 100.00

Research Provided by a Third Party

Company: Tandem Diabetes Care, Inc.

Industry: Medical - Instruments

Record: 19

03/30/2017

Company Report

Pages: 12

Best-In-Class Insulin Pump Portfolio, Upcoming Inflection Point in Sales Growth, and Attractive Valuation; Reiterate OUTPERFORM

Provider: Wedbush Securities Inc.

Price: 25.00

Research Provided by a Third Party

Company: Tandem Diabetes Care, Inc.

Industry: Medical - Instruments

Record: 20

01/24/2017

Industry Report

Pages: 6

Medical Devices: Diabetes Market Implications from JNJ''s Potential Exit

Provider: Wedbush Securities Inc.

Price: 25.00

Research Provided by a Third Party